Ignite Creation Date:
2024-05-06 @ 9:01 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02888964
Status:
COMPLETED
Last Update Posted:
2016-09-08
First Post:
2016-08-19
Brief Title:
Pioglityazone and Imatinib for CML Patients
Sponsor:
Versailles Hospital
Organization:
Versailles Hospital
Organization Data
Organization:
Versailles Hospital
Class:
OTHER
Study ID:
0937_ACTIM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Versailles Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Philippe ROUSSELOT
Responsible Party Title:
Study Coordinator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Versailles Hospital
Old Name:
None
Old Organization:
None